These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome. Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214 [TBL] [Abstract][Full Text] [Related]
23. Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia. Waddell-Smith KE; Ertresvaag KN; Li J; Chaudhuri K; Crawford JR; Hamill JK; Haydock D; Skinner JR; Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1151-8. PubMed ID: 26224781 [TBL] [Abstract][Full Text] [Related]
24. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest. Campbell MJ; Czosek RJ; Hinton RB; Miller EM Am J Med Genet A; 2015 Sep; 167A(9):2197-200. PubMed ID: 26018045 [TBL] [Abstract][Full Text] [Related]
25. Development of Dilated Cardiomyopathy in a Young Woman After Bilateral Cardiac Sympathetic Denervation in Catecholaminergic Polymorphic Ventricular Tachycardia. Janiec K; Krawczykiewicz R Cureus; 2022 Dec; 14(12):e32406. PubMed ID: 36636545 [TBL] [Abstract][Full Text] [Related]
26. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature. Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648 [TBL] [Abstract][Full Text] [Related]
27. Catecholaminergic Polymorphic Ventricular Tachycardia. Lieve KV; van der Werf C; Wilde AA Circ J; 2016 May; 80(6):1285-91. PubMed ID: 27180891 [TBL] [Abstract][Full Text] [Related]
28. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia. Arakawa J; Hamabe A; Aiba T; Nagai T; Yoshida M; Touya T; Ishigami N; Hisadome H; Katsushika S; Tabata H; Miyamoto Y; Shimizu W Heart Vessels; 2015 Nov; 30(6):835-40. PubMed ID: 25092222 [TBL] [Abstract][Full Text] [Related]
29. Anesthetic management of a child with catecholaminergic polymorphic ventricular tachycardia undergoing insertion of implantable cardioverter defibrillator : a case report. Omiya K; Mitsui K; Matsukawa T JA Clin Rep; 2020 Feb; 6(1):16. PubMed ID: 32103353 [TBL] [Abstract][Full Text] [Related]
30. A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia. Claudio B; Alice M; Daniel S Mini Rev Med Chem; 2018; 18(6):476-482. PubMed ID: 28685702 [TBL] [Abstract][Full Text] [Related]
31. [Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children]. Ge HY; Li XM; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li MT Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):926-931. PubMed ID: 29262473 [No Abstract] [Full Text] [Related]
32. Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia. Liu B; Walton SD; Ho HT; Belevych AE; Tikunova SB; Bonilla I; Shettigar V; Knollmann BC; Priori SG; Volpe P; Radwański PB; Davis JP; Györke S J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720499 [TBL] [Abstract][Full Text] [Related]
33. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report. Garabedian L; Verryckt A; Panzer J; De Wolf D Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993 [TBL] [Abstract][Full Text] [Related]